Hovagim Bakardjian’s research while affiliated with French Institute of Health and Medical Research and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (104)


Example trial of the old/new word-recognition task. Translation: 1) “Avez-vous déjà vu ce mot?” aka. Have you seen this word before? 2) “Etes-vous sûr de votre dernière response?” aka. Are you sure of your response?
Flowchart of the number of participants from INSIGHT-preAD cohort included in each session of this study
Accuracy performance in the old/new recognition task across the M0 to M60 sessions for each stable group (controls, stable/N−, and stable/N +). In each plot, the mean accuracy (in rate of correct responses) is represented for each group (comprising n = 175, 57, and 16 participants at M0, respectively), for each word category (NR words in blue, NU words in green, old words in red), and for every session (M0 to M60). Thin vertical lines represent the standard errors of the means
dprime [d′] and response criterion across sessions in the old/new word-recognition task, in the controls, stable/N− and stable/N + groups. The mean dprime on the left plots and the mean criterion on the right plots (in ordinate) are represented for each group at every session (M0 to M60, in abscissa)
Reaction time [RT] to the old/new word-recognition task on each session (M0 to M60) in each stable group (controls, stable/N−, and stable/N +). In each plot, the mean RT (in ms, in ordinate) is presented per group (n = 175, 57, and 16 participants at M0, respectively), for each word category (NR words in blue, NU words in green, Old words in red), at every session (M0 to M60). Vertical lines represent the standard errors of the means

+3

Recognition memory decline is associated with the progression to prodromal Alzheimer’s disease in asymptomatic at-risk individuals
  • Article
  • Publisher preview available

December 2024

·

23 Reads

Journal of Neurology

Filipa Raposo Pereira

·

·

Bruno Dubois

·

[...]

·

Episodic memory (EM) alterations are a hallmark of Alzheimer’s disease (AD). We assessed EM longitudinally in cognitively normal elders at-risk for AD (with subjective memory complaints), as a function of amyloid-β (Aβ) burden, neurodegeneration (N), and progression to prodromal AD. We stratified 264 INSIGHT-preAD study subjects in controls (Aβ-/N−), stable/N− or N + (Aβ +), and progressors/N− or N + (Aβ +) groups (progressors were included only until AD-diagnosis). We used linear mixed-effect models with Aβ and N status, or progression to AD as factors, to analyze behavioral performance in an old/new word-recognition task based on the free and cued selective reminding test (FCSRT). The controls and stable/N− groups showed near-ceiling accuracy and RT improvement across follow-up. The stable/N + group showed accuracy reduction and no RT improvement, i.e., Aβ + /N + cumulative effect. The progressors showed a marked performance decline. EM alterations may constitute early preclinical markers of progression to prodromal AD, while individuals are cognitively normal according to neuropsychological standards.

View access options



Theta-band power distribution on the brain surface at the time of the first visit (i.e., M0). Panel (a) depicts the grand-mean across the whole sample. Panel (b) shows the difference between A+ and A–. Values are expressed in z-scores. Panel (c) highlights the contrast between the groups (i.e., A– versus A+) computed through an independent-samples t-test. Significant probabilities are corrected at cluster-level by means of a Monte Carlo permutation approach. Note: negative t-test (in cyan) on the mid-frontal brain regions reflects ampler theta-power for A+ relative to A–. Panel (d) depicts the significant increase of theta-power as a function of amyloid deposition. Continuous values of amyloid are distributed in 7 quantiles, each including averaged theta-power values of ∼38 subjects. In this, individuals with highest amyloid deposition (i.e., quantile 7; A+) shows a higher (**p < 0.001) increase of mid-frontal theta-band power with respect to A– (i.e., quantiles 1–5). A moderate effect (*p < 0.01) is also shown between the middle (i.e., quantile 4) and medium-high stages of amyloid deposition. Vertical bars indicate 95% confidence interval. The scatterplot in panel (e) shows the linear regression between continuous values of amyloid and mid-frontal theta power.
Link between mid-frontal theta-band power, amyloid deposition, and APOE genotype. Left-column depicts the theta-power distribution on the brain surface (left-column) as a function of the amyloid (i.e., A– versus A+) and APOE (i.e., ɛ4–versus ɛ4+) status. The bar-plot (right-column) represents the variation of mid-frontal theta power as a function of amyloid (i.e., A– versus A+) and APOE (i.e., ɛ4–versus ɛ4+) status.
Link between mid-frontal theta-band power and memory performance (FCSRT-TR). Panel (a) shows the linear regression model carried out on the whole sample. Panel (b) depicts the same model performed on A– (left-column) and A+(right-column), separately. All the plot shows the raw data (black/green/red stars), the fit of the model (red straight-line) with 95% confidence interval (red curved-line), its slope (β-coefficients) and the associated p-value.
Theta- and Alpha-low band power distribution on the brain surface at the time of the second visit (i.e., M24). Panel (a) depicts the grand-mean across the whole sample for A– and A+ as well as the difference between A+ and A–. Power-values are expressed in z-scored as for M0. Panel (b) shows the independent-samples t-test computed between A– and A+. Negative t-test (in cyan) reflects ampler band-power for A+ with respect to A–; positive t-test (in magenta) reflects lower band-power for A+ with respect to A–. Importantly, significant probabilities are cluster-corrected for theta-band (left-column) and not at all corrected for alpha-low (right-column).
Demographic characteristics, global cognitive profile, amyloid sta- tus, and APOE genotype of the sample
Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer’s Disease

September 2022

·

56 Reads

·

15 Citations

Background Alzheimer’s disease (AD) includes progressive symptoms spread along a continuum of preclinical and clinical stages. Although numerous studies uncovered the neuro-cognitive changes of AD, very little is known on the natural history of brain lesions and modifications of brain networks in elderly cognitively-healthy memory complainers at risk of AD for carrying pathophysiological biomarkers (amyloidopathy and tauopathy). Objective We analyzed resting-state electroencephalography (EEG) of 318 cognitively-healthy subjective memory complainers from the INSIGHT-preAD cohort at the time of their first visit (M0) and two-years later (M24). Methods Using ¹⁸F-florbetapir PET-scanner, subjects were stratified between amyloid negative (A–; n = 230) and positive (A+; n = 88) groups. Differences between A+ and A– were estimated at source-level in each band-power of the EEG spectrum. Results At M0, we found an increase of theta power in the mid-frontal cortex in A+ compared to A–. No significant association was found between mid-frontal theta and the individuals’ cognitive performance. At M24, theta power increased in A+ relative to A– individuals in the posterior cingulate cortex and the pre-cuneus. Alpha band revealed a peculiar decremental trend in posterior brain regions in the A+ relative to the A– group only at M24. Theta power increase over the mid-frontal and mid-posterior cortices suggests an hypoactivation of the default-mode network in the A+ individuals and a non-linear longitudinal progression at M24. Conclusion We provide the first source-level longitudinal evidence on the impact of brain amyloidosis on the EEG dynamics of a large-scale, monocentric cohort of elderly individuals at-risk for AD.


Theta band-power shapes amyloid-driven longitudinal EEG changes in pre-clinical Alzheimer's Disease

February 2022

·

49 Reads

·

2 Citations

Alzheimer's Disease (AD) includes progressive symptoms spread along a continuum of pre-clinical (pre-AD) and clinical stages. Pre-AD refers to cognitively healthy individuals with presence of positive pathophysiological biomarkers of AD (i.e., markers of amyloidopathy and tauopathy). Although numerous studies uncovered the neuro-cognitive changes of AD, very little is known on the natural history of brain lesions and modifications of brain networks of pre-AD. To address this issue, we analysed resting-state EEG data of 318 cognitively healthy individuals with subjective memory complains from the INSIGHT-preAD cohort at the time of their first visit (M0) and two-years later (M24). Using 18F-florbetapir PET-scanner, subjects were stratified between amyloid positive (A-; n=230) and amyloid negative (A+; n=88) groups. Differences between A+ and A- individuals were estimated at source level in each band of the EEG power spectrum. At M0, we found an increase of theta-band power in the mid-frontal cortex in A+ compared to A-. No significant association was found between mid-frontal theta power and the individuals' cognitive performance. While the very same effect was not replicated at M24, theta-band power increased in A+ relative to A- individuals in the posterior cingulate cortex and the pre-cuneus. Furthermore, alpha band revealed a peculiar decremental trend in posterior brain regions in the A+ relative to the A- group only at M24. These results provide the first source-level longitudinal evidence on the impact of brain amyloidosis on the EEG dynamics of a large-scale, monocentric cohort of pre-AD. Theta-band power increase over the mid-frontal and mid-posterior cortices suggests an hypoactivation of the default-mode network in individuals at-risk of AD and a non-linear longitudinal progression of the AD-spectrum.


Education and brain amyloid load act on temporal lobe function in individual with subjective memory complaint: An EEG‐fMRI study

December 2021

·

48 Reads

Background The cognitive reserve (CR) moderate the effect of brain pathophysiology on cognitive deficits in Alzheimer's Disease (AD) continuum. In a previous study on individuals with subjective memory complaint (SMCs), a condition at risk for AD, from the INSIGHT‐preAD cohort, we found that CR altered the association of amyloid load with neurophysiological mechanisms generating posterior electroencephalographic (EEG) alpha rhythms in quiet wakefulness. We used educational attainment (Edu) as an indicator of CR. Method In the present work we tested the hypothesis of the interaction of Edu and cerebral amyloid‐b load with the association between posterior alpha rhythms, as revealed by resting‐state EEG (rsEEG) activity, and functional connectivity, as revealed by functional magnetic resonance imaging (fMRI, 3‐Tesla Verio system), among cholinergic basal forebrain (BF), thalamus, and posterior cortical areas. Resting‐state EEG and fMRI data were acquired in 318 cognitively intact individuals (age between 70 and 85 years) with SMC. Participants were stratified into two groups of amyloid‐positive (SMCpos) and ‐negative (SMCneg), using the standard diagnostic markers of Alzheimer's neuropathology based on cortical‐to‐cerebellum standardized uptake value ratio in the PET imaging. Then, the education attainment level was used to stratify the SMC participants in those with a low‐to‐moderate education level (SMC Edu‐) and those with a high education level (SMC Edu+). Result Results showed a significant positive association between temporal alpha rhythms and above‐mentioned functional connectivity in the SMC cases with low brain amyloid accumulation and education attainment (SMCneg Edu‐). In contrast, the SMCneg Edu+ seniors showed the amplest posterior alpha rhythms, but not a positive association between temporal alpha rhythms and fMRI connectivity among cholinergic BF, thalamus, and posterior cerebral cortex, possibly due to a (annulation) of high CR. Of note, the SMCpos Edu+ seniors showed this positive association, possibly due to the (neutralization) of CR and brain amyloidosis (Figure 1). Conclusion The present results suggest that, in SMC seniors, high CR affects cortical neural synchronization mechanisms generating posterior rsEEG alpha rhythms, but not through the ascending cholinergic system to the posterior cortex. Unfortunately, these CR effects may be annulled at earlier stages of Alzheimer's amyloid pathophysiology.


Fig. 1 miRNA15b is significantly lower in the Aβ-PET negative subgroup compared with the Aβ-PET positive. *Kruskal-Wallis one-way ANOVA on ranks test; p value: 0.045 (see Table 1 for descriptive data). Plasma miR-15b concentration is reported in terms of relative quantity. PET positron emission tomography, Aβ amyloid beta, n.s. not significant, miRNA microRNA.
Sociodemographic features, APOE ε4 allele frequencies, and plasma concentrations of the six identified brain- enriched miRNAs.
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

June 2021

·

394 Reads

·

26 Citations

Translational Psychiatry

There is substantial experimental evidence for dysregulation of several microRNA (miRNA) expression levels in Alzheimer’s disease (AD). MiRNAs modulate critical brain intracellular signaling pathways and are associated with AD core pathophysiological mechanisms. First, we conducted a real-time quantitative PCR-based pilot study to identify a set of brain-enriched miRNAs in a monocentric cohort of cognitively normal individuals with subjective memory complaints, a condition associated with increased risk of AD. Second, we investigated the impact of age, sex, and the Apolipoprotein E ε4 (APOE ε4) allele, on the identified miRNA plasma concentrations. In addition, we explored the cross-sectional and longitudinal association of the miRNAs plasma concentrations with regional brain metabolic uptake using amyloid-β (Aβ)-positron emission tomography (Aβ-PET) and 18F-fluorodeoxyglucose-PET (18F-FDG-PET). We identified a set of six brain-enriched miRNAs—miRNA-125b, miRNA-146a, miRNA-15b, miRNA-148a, miRNA-26b, and miRNA-100. Age, sex, and APOE ε4 allele were not associated with individual miRNA abundance. MiRNA-15b concentrations were significantly lower in the Aβ-PET-positive compared to Aβ-PET-negative individuals. Furthermore, we found a positive effect of the miRNA-15b*time interaction on regional metabolic 18F-FDG-PET uptake in the left hippocampus. Plasma miRNA-125b concentrations, as well as the miRNA-125b*time interaction (over a 2-year follow-up), were negatively associated with regional Aβ-PET standard uptake value ratio in the right anterior cingulate cortex. At baseline, we found a significantly negative association between plasma miRNA-125b concentrations and 18F-FDG-PET uptake in specific brain regions. In an asymptomatic at-risk population for AD, we show significant associations between plasma concentrations of miRNA-125b and miRNA-15b with core neuroimaging biomarkers of AD pathophysiology. Our results, coupled with existing experimental evidence, suggest a potential protective anti-Aβ effect of miRNA-15b and a biological link between miRNA-125b and Aβ-independent neurotoxic pathways.


Sensitivity and specificity of EEG biomarkers of AD at the preclinical stage: Biomarkers (non‐neuroimaging) / novel biomarkers

December 2020

·

49 Reads

Background Cognitive reserve (CR) is present in Alzheimer’s disease (AD) seniors with high education attainment making them clinically resilient to extended brain neuropathology and neurodegeneration. Here we tested whether subjective memory complaint (SMC) seniors with AD neuropathology and high education attainment may present abnormal eyes‐closed resting state posterior electroencephalographic (rsEEG) rhythms around individual alpha frequency peak (IAFp), typically altered in AD patients with mild cognitive impairment and dementia. Method We selected all individual baseline data of the prospective INSIGHT‐preAD cohort (Paris) including mini mental state examination score ≥ 28, artifact‐free markers of 18F‐florbetapir positron emission tomography (amyPET), structural magnetic resonance imaging, and rsEEG rhythms (e.g., 172 SMC seniors). Delta, theta, alpha1, alpha2, and alpha3 bands were determined on individual basis based on IAFp, while beta1 (14‐20 Hz), beta2 (20‐30 Hz), and gamma (30‐40 Hz) were standard fixed bands. Result The SMC participants negative to amyPET AD markers (SMCneg) with high (over low‐moderate) education level showed higher posterior alpha 2 power density (possibly “neuroprotective”). Furthermore, amyPET‐positive SMC (SMCpos) participants with high (over low‐moderate) education level showed higher temporal alpha 3 power density (possibly “neuroprotective”) and lower posterior alpha 2 power density (possibly “compensatory”; Figure 1). This effect may reflect CR as no differences in brain gray‐white matter and cognitive functions were observed between these SMCpos/SMCneg sub‐groups. Conclusion Preclinical Alzheimer’s neuropathology may interact with education attainment and neurophysiological mechanisms generating cortical alpha rhythms around IAFp (i.e., alpha 2 and 3) in quiet wakefulness.


Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers

December 2020

·

25 Reads

·

11 Citations

Neurobiology of Aging

Neuroinflammation, a key early pathomechanistic alteration of Alzheimer's disease, may represent either a detrimental or a compensatory mechanism or both (according to the disease stage). YKL-40, a glycoprotein highly expressed in differentiated glial cells, is a candidate biomarker for in vivo tracking neuroinflammation in humans. We performed a longitudinal study in a monocentric cohort of cognitively healthy individuals at risk for Alzheimer's disease exploring whether age, sex, and the apolipoprotein E ε4 allele affect plasma YKL-40 concentrations. We investigated whether YKL-40 is associated with brain amyloid-β (Aβ) deposition, neuronal activity, and neurodegeneration as assessed via neuroimaging biomarkers. Finally, we investigated whether YKL-40 may predict cognitive performance. We found an age-associated increase of YKL-40 and observed that men display higher concentrations than women, indicating a potential sexual dimorphism. Moreover, YKL-40 was positively associated with memory performance and negatively associated with brain Aβ deposition (but not with metabolic signal). Consistent with translational studies, our results suggest a potentially protective effect of glia on incipient brain Aβ accumulation and neuronal homeostasis.


EEG: A valuable tool to screen for neurodegeneration in preclinical Alzheimer’s disease: Biomarkers (non‐neuroimaging): EEG and other biomarkers

December 2020

·

44 Reads

·

3 Citations

Background Early biomarkers are needed to identify individuals at high risk of preclinical Alzheimer’s disease (AD) (Jack et al. , 2018). Electroencephalography (EEG) is a non‐invasive and cheap technique that would be an interesting screening tool for the preclinical stage of AD. Method We included participants from the INSIGHT‐preAD cohort, which is an ongoing single‐center multimodal observational study designed to identify risk factors and markers of progression to clinical AD in 318 cognitively normal individuals aged 70–85 years with a subjective memory complaint (Dubois et al. , 2018). We divided the subjects into four groups, according to their amyloid status (on ¹⁸ F‐florbetapir PET) and neurodegeneration status (on ¹⁸F‐fluorodeoxyglucose PET). We analysed 314 baseline 256‐channel high‐density eyes‐closed 1‐minute resting‐state EEG recordings. We extracted 10 quantitative EEG biomarkers, including spectral measures, algorithmic complexity and functional connectivity metrics. We evaluated three different classifiers (random forest, decision tree and logistic regression) to predict amyloid and neurodegeneration status from multimodal data, combining EEG, ApoE4 genotype, demographic, neuropsychological and MRI data. We divided the dataset into a training set (n=258) and validation set (n=46). We used a 5‐fold cross‐validation on the training set to identify the optimal combination of features. Result As recently published (Gaubert et al. , 2019), the most prominent effects of neurodegeneration on EEG metrics were localized in fronto‐central regions with an increase in high‐frequency oscillations (higher beta and gamma power) and a decrease in low‐frequency oscillations (lower delta power), higher spectral entropy, higher complexity and increased functional connectivity measured by weighted Symbolic Mutual Information in theta band. In the machine learning analysis, among the different features, EEG was the most strongly predictive of neurodegeneration. Similar predictive performance was obtained when reducing the number of electrodes from 256 to 8. EEG biomarkers combined with hippocampal volumetry had a high negative predictive value (91%) and high sensitivity (82%) to predict neurodegeneration. The combination of ApoE4 genotype with demographic data was most strongly predictive of amyloid status. Conclusion EEG could be a valuable tool to screen for or rule out neurodegeneration in elderly memory complainers. This procedure has been patented under the following PCT number: PCT/EP2019/086629.


Citations (70)


... Apart from neuropsychological parameters, resting-state EEG indices may be a promising candidate as an electrophysiological measure of VR training effectiveness (Thapa et al., 2020;Yang et al., 2022). In resting-state EEG rhythms, increases or decreases in signal power/intensity and latency could reflect resource allocation mechanisms and other neurophysiological changes preceding goal-directed behavior (Buján et al., 2022;Finnigan & Robertson, 2011;Lopez et al., 2024). The EEG signals have been proven to be an effective tool in clinical and non-clinical settings, containing information concerning cognitive, emotional, and physiological processes related to changes in brain electrical activity (Päeske et al., 2023). ...

Reference:

VR Cognitive-based Intervention for Enhancing Cognitive Functions and Well-being in Older Adults with Mild Cognitive Impairment: Behavioral and EEG Evidence
The Association between Posterior Resting-State EEG Alpha RhythmS and Functional MRI Connectivity in Older Adults with Subjective Memory Complaint

Neurobiology of Aging

... P = 0.006**; Supplementary Table 17). CHI3L1 is highly expressed in astrocytes during neuroinflammation and is associated with increased brain amyloid and AD symptoms 34,35 . ...

Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers
  • Citing Article
  • December 2020

Neurobiology of Aging

... The correlation between the increasing neuropathological changes and cognitive impairment defines electrophysiological brain changes and the electrophysiological biomarker in the rsEEG theta frequency [42]. An increasing rsEEG theta can be described as an indicator of a change in the brain's electrophysiology from plaques and tangles negatively impacting neural activity [43,44]. This rsEEG theta can be described as a way to detect and measure cognitive impairment in persons with MCI and AD without being dependent on brain activity changes reaching a certain threshold for detection [43,44]. ...

Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer’s Disease

... As stated earlier, theta rhythms appear in physiological states but also can be considered as non-specific markers of neurological disorders. Some authors have suggested that subtle changes in theta and gamma rhythms occur during the very early stages of AD and could be used as a possible predictor for the disease [30,203]. A disruption of oscillatory network activity has been detected in the EEG of AD patients [31] and transgenic AD animals [204]. ...

Theta band-power shapes amyloid-driven longitudinal EEG changes in pre-clinical Alzheimer's Disease

... Interestingly, circulating RNAs in the blood, especially microR-NAs (miRNAs), have shown promise as biomarkers for the diagnosis of preclinical or early stages of AD [116][117][118][119]. Several miRNAs have been identified as potential biomarkers for predicting the progression from MCI to AD [120]. Moreover, in preclinical AD, the combination of biomarkers, such as microRNA, p-tau181, NfL, GFAP, and Aβ 42/40 with amyloid PET or cognitive function tests, including ADAS-Cog13 and MMSE, allows for earlier and more accurate detection of AD [120][121][122]. ...

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

Translational Psychiatry

... Alzheimer's Disease (AD) is a degenerative Neurological disorder, with typical symptoms of poor cognitive status, affective symptoms, psychomotor dysregulation, etc [1]. The pathology of AD is associated with β-amyloid (Aβ) protein plaquing and tau protein hyperphosphorylation [2]. AD as a Central Neural System (CNS) disorder has affected 26.6 million people worldwide and is estimated to increase in the population for 1 out of 85 people by reaching 2050 [3]. ...

Association of plasma YKL-40 with brain amyloid-b levels, memory performance, and sex in subjective memory complainers

Neurobiology of Aging

... EEG is one of the most promising tools in search for LOAD diagnostic markers [11,12], as it has high availability, low cost and non-invasiveness. The most common protocol used in AD patients is the "resting-state" protocol, as it is brief and does not require participants to engage in any specific task. ...

EEG: A valuable tool to screen for neurodegeneration in preclinical Alzheimer’s disease: Biomarkers (non‐neuroimaging): EEG and other biomarkers
  • Citing Article
  • December 2020

... Cacciamani et al. 51 estimating the discrepancy between the score on the Healthy Aging Brain Care Monitor of participants and their study partners. This is a questionnaire asking about difficulties in everyday life. ...

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD

Alzheimer's Research & Therapy

Federica Cacciamani

·

·

·

[...]

·

M. Vlaincu

... [12][13][14] The plasma amyloid beta (Aβ) 42/40 ratio and phosphorylated tau (ptau) are disease-specific biomarkers of Aβ and tau pathologies and have been recommended in recent Alzheimer's Association criteria for diagnosing AD when shown to have at least 90% accuracy in comparison to amyloid PET or CSF assays. 15 The diagnostic performance of plasma Aβ42/40 is relatively lower with the area under the receiver operating characteristic (ROC) curve (AUC) of less than 90%, [16][17][18] while p-tau (eg, tau phosphorylated at threonine 217 [p-tau217], p-tau231, p-tau181) ...

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
  • Citing Article
  • June 2019

Alzheimer's & Dementia